DK0872238T3 - Anvendelse af olanzapin til fremstilling af et medikament til neuroprotektin - Google Patents

Anvendelse af olanzapin til fremstilling af et medikament til neuroprotektin

Info

Publication number
DK0872238T3
DK0872238T3 DK98302789T DK98302789T DK0872238T3 DK 0872238 T3 DK0872238 T3 DK 0872238T3 DK 98302789 T DK98302789 T DK 98302789T DK 98302789 T DK98302789 T DK 98302789T DK 0872238 T3 DK0872238 T3 DK 0872238T3
Authority
DK
Denmark
Prior art keywords
olanzapine
neuroprotectin
drug
manufacture
neuro
Prior art date
Application number
DK98302789T
Other languages
English (en)
Inventor
Franklin Porter Bymaster
Gary Dennis Tollefson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0872238T3 publication Critical patent/DK0872238T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK98302789T 1997-04-15 1998-04-09 Anvendelse af olanzapin til fremstilling af et medikament til neuroprotektin DK0872238T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4309497P 1997-04-15 1997-04-15

Publications (1)

Publication Number Publication Date
DK0872238T3 true DK0872238T3 (da) 2002-06-24

Family

ID=21925472

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98302789T DK0872238T3 (da) 1997-04-15 1998-04-09 Anvendelse af olanzapin til fremstilling af et medikament til neuroprotektin

Country Status (8)

Country Link
EP (1) EP0872238B1 (da)
AT (2) ATE260662T1 (da)
AU (1) AU6955998A (da)
DE (2) DE69822234T2 (da)
DK (1) DK0872238T3 (da)
ES (2) ES2173550T3 (da)
PT (2) PT1155696E (da)
WO (1) WO1998046596A1 (da)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
US5605897A (en) * 1991-04-23 1997-02-25 Eli Lilly And Company 2-methyl-thieno-benzodiazepine
US5627178A (en) * 1991-04-23 1997-05-06 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use
US5536718A (en) * 1995-01-17 1996-07-16 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5696115A (en) * 1995-04-21 1997-12-09 Eli Lilly And Company Method for treating nicotine withdrawal
US5744470A (en) * 1996-03-11 1998-04-28 Eli Lilly And Company Method for treating insomnia
US5744469A (en) * 1996-11-26 1998-04-28 Eli Lilly And Company Method for treating dermatitis

Also Published As

Publication number Publication date
EP0872238A2 (en) 1998-10-21
PT1155696E (pt) 2004-06-30
ES2215851T3 (es) 2004-10-16
AU6955998A (en) 1998-11-11
ATE213945T1 (de) 2002-03-15
EP0872238A3 (en) 1998-10-28
ES2173550T3 (es) 2002-10-16
DE69804034T2 (de) 2002-10-17
DE69822234T2 (de) 2005-02-24
ATE260662T1 (de) 2004-03-15
WO1998046596A1 (en) 1998-10-22
PT872238E (pt) 2002-07-31
DE69822234D1 (de) 2004-04-08
DE69804034D1 (de) 2002-04-11
EP0872238B1 (en) 2002-03-06

Similar Documents

Publication Publication Date Title
FI955782L (fi) Menetelmä kivun käsittelemiseksi 24-tunnin suun kautta annettavia opioidiformulointeja, joilla saadaan lääkkeen plasmatason nopea alkunousu
DK1041990T3 (da) Præparat til behandling af respiratoriske sygdomme og hudsygdomme med mindst en leukotrien-antagonist og mindst et antihistamin
FI931915A7 (fi) Ionihoidon lääkkeen antoelektrodi ja menetelmä sen hydroimiseksi
NO981146L (no) Transcytotiske midler og forsterkere for medikamentleveranser
NO994014D0 (no) Arylsulfonamider og analoger derav og deres anvendelse for behandling av neurodegenerative sykdommer
DK0668763T3 (da) Anvendelse af phenserin til fremstillingen af lægemidler til behandlingen af kognitive sygdomme
ATE339954T1 (de) Kombinationen von formoterol und tiotropium-salz
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
ATA903796A (de) Elektrotransporteinrichtung zur verabreichung eines als fentanylsalz oder als sufentanilsalz vorliegenden analgetischen medikaments
NO20003229D0 (no) Kombinasjon av benzosykloheptapyridinforbindelser og antineoplastiske legemidler for behandling av proliferaktive sykdommer
BR0307022A (pt) Método de tratamento de um paciente que precisa de analgesia
FI973185L (fi) Melatoniinin käyttö lääkeriippuvuudesta kärsivien potilaiden hoitoon
DK0879054T3 (da) Anvendelse af pyrrolidionderivater til fremstilling af medikamenter til behandling af narkotikamisbrug
NO20012226L (no) Terapeutiske midler for medikamentavhengighet
NO984196D0 (no) Fremgangsmåte for behandling av stoffmisbruk
DK0872239T3 (da) Anvendelse af olanzapin til fremstilling af et lægemiddel til behandling af cerebral fokal iskæmi
DK0670721T3 (da) Lægemiddel til behandling og forebyggelse af knogle- og ledsygdomme
PT1155696E (pt) Utilizacao de olanzapina para fabrico de um medicamento para neuroproteccao
YU40098A (sh) Upotreba olanzapina za dobijanje leka
YU40198A (sh) Postupak za tretiranje zavisnosti od supstance
EA199800820A1 (ru) Способ лечения злоупотребления лекарственными средствами
SE9300725D0 (sv) New use of composition for administration of drugs and method for administration of drugs
ITTO920519A1 (it) Sussidio terapeutico dinamico per la rieducazione sensitivo-motoria dell'arto superiore in pazienti cerebrolesi.